Neuropeptide Y, B‐type natriuretic peptide, substance P and peptide YY are novel substrates of fibroblast activation protein‐α
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Fibroblast activation protein‐α (FAP) is a cell surface‐expressed and soluble enzyme of the prolyl oligopeptidase family, which includes dipeptidyl peptidase 4 (DPP4). FAP is not generally expressed in normal adult tissues, but is found at high levels in activated myofibroblasts and hepatic stellate cells in fibrosis and in stromal fibroblasts of epithelial tumours. FAP possesses a rare catalytic activity, hydrolysis of the post‐proline bond two or more residues from the N‐terminus of target substrates. α 2‐antiplasmin is an important physiological substrate of FAP endopeptidase activity. This study reports the first natural substrates of FAP dipeptidyl peptidase activity. Neuropeptide Y, B‐type natriuretic peptide, substance P and peptide YY were the most efficiently hydrolysed substrates and the first hormone substrates of FAP to be identified. In addition, FAP slowly hydrolysed other hormone peptides, such as the incretins glucagon‐like peptide‐1 and glucose‐dependent insulinotropic peptide, which are efficient DPP4 substrates. FAP showed negligible or no hydrolysis of eight chemokines that are readily hydrolysed by DPP4. This novel identification of FAP substrates furthers our understanding of this unique protease by indicating potential roles in cardiac function and neurobiology. Structured digital abstract FAP cleaves GLP‐1‐amide by protease assay (View interaction) DPP4 cleaves PACAP by protease assay (View interaction) FAP cleaves PYY by protease assay (View interaction) FAP cleaves NPY by protease assay (View interaction) DPP4 cleaves Substance P by protease assay (View interaction) DPP4 cleaves GIP by protease assay (View interaction) DPP4 cleaves CCL11‐Eotaxin by protease assay (View interaction) DPP4 cleaves GLP‐1‐amide by protease assay (View interaction) DPP4 cleaves CXCL12‐SDF1 by protease assay (View interaction) FAP cleaves GRF by protease assay (View interaction) FAP cleaves GLP‐2 by protease assay (View interaction) DPP4 cleaves Glucagon by protease assay (View interaction) FAP cleaves BNP by protease assay (View interaction) DPP4 cleaves CXCL2‐GRO by protease assay (View interaction) DPP4 cleaves CCL22‐MDC by protease assay (View interaction) DPP4 cleaves CXCL9‐MIG by protease assay (View interaction) FAP cleaves GIP by protease assay (View interaction) DPP4 cleaves GRF by protease assay (View interaction) DPP4 cleaves CXCL11 ITAC by protease assay (View interaction) FAP cleaves Substance P by protease assay (View interaction) DPP4 cleaves VIP by protease assay (View interaction) DPP4 cleaves CCL5 ‐RANTES by protease assay (View interaction) DPP4 cleaves PHM by protease assay (View interaction) DPP4 cleaves Oxyntomodulin by protease assay (View interaction) DPP4 cleaves CXCL10‐IP10 by protease assay (View interaction) DPP4 cleaves PYY by protease assay (View interaction) DPP4 cleaves BNP by protease assay (View interaction) DPP4 cleaves GLP‐2 by protease assay (View interaction) DPP4 cleaves NPY by protease assay (View interaction) FAP cleaves PHM by protease assay (View interaction)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MENTLEIN, R., GALLWITZ, B., & SCHMIDT, W. E. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb17986.x · Cited by 1,161
Suppression of Antitumor Immunity by Stromal Cells Expressing Fibroblast Activation Protein–α
Kraman, M., Bambrough, P. J., Arnold, J. N., Roberts, E. W., Magiera, L., Jones, J. O., Gopinathan, A., Tuveson, D. A., & Fearon, D. T. (2010) · Science · doi:10.1126/science.1195300 · Cited by 1,134
Kieffer, T. J., McIntosh, C. H., & Pederson, R. A. (1995) · Endocrinology · doi:10.1210/endo.136.8.7628397 · Cited by 1,124
Deacon, C. F., Johnsen, A. H., & Holst, J. J. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.3.7883856 · Cited by 792
Kuo, L. E., Kitlinska, J. B., Tilan, J. U., Li, L., Baker, S. B., Johnson, M. D., Lee, E. W., Burnett, M. S., Fricke, S. T., Kvetnansky, R., et al. (2007) · Nature Medicine · doi:10.1038/nm1611 · Cited by 656
Cited by
Lindner, T., Loktev, A., Altmann, A., Giesel, F., Kratochwil, C., Debus, J., Jäger, D., Mier, W., & Haberkorn, U. (2018) · Journal of Nuclear Medicine · doi:10.2967/jnumed.118.210443 · Cited by 935
A Tumor-Imaging Method Targeting Cancer-Associated Fibroblasts
Loktev, A., Lindner, T., Mier, W., Debus, J., Altmann, A., Jäger, D., Giesel, F., Kratochwil, C., Barthe, P., Roumestand, C., et al. (2018) · Journal of Nuclear Medicine · doi:10.2967/jnumed.118.210435 · Cited by 777
Pharmacology, Physiology, and Mechanisms of Action of Dipeptidyl Peptidase-4 Inhibitors
Mulvihill, E. E., & Drucker, D. J. (2014) · Endocrine Reviews · doi:10.1210/er.2014-1035 · Cited by 609
The role of fibroblast activation protein in health and malignancy
Fitzgerald, A. A., & Weiner, L. M. (2020) · Cancer and Metastasis Reviews · doi:10.1007/s10555-020-09909-3 · Cited by 589
Hamson, E. J., Keane, F. M., Tholen, S., Schilling, O., & Gorrell, M. D. (2014) · PROTEOMICS – Clinical Applications · doi:10.1002/prca.201300095 · Cited by 496
Self-citation
Metadata
- Authors
- Keane, F. M., Nadvi, N. A., Yao, T., & Gorrell, M. D.
- Venue
- The FEBS Journal
- Publisher
- Wiley
- Published
- 2011-03-09
- Volume
- 278
- Issue
- 8
- Pages
- 1316-1332
- ISSN
- 1742-464X (ISSN-L)
- 1742-4658
- OpenAlex
- W1545804167
- Cited by
- 124
- References
- 5
- FWCI
- 3.45
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Neuropeptide Y, B‐type natriuretic peptide, substance P and peptide YY are novel substrates of fibroblast activation protein‐α. https://app.cochat.ai/papers/10.1111/j.1742-4658.2011.08051.x
- The paper
- Keane, F. M., Nadvi, N. A., Yao, T., & Gorrell, M. D. (2011). Neuropeptide Y, B‐type natriuretic peptide, substance P and peptide YY are novel substrates of fibroblast activation protein‐α. The FEBS Journal. https://doi.org/10.1111/j.1742-4658.2011.08051.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.